Abstract
The mast cell (MC) activation assay is a robust in vitro tool for exploring MC reactivity in allergy. Here we describe the use of the mast cell activation test (MAT) that makes use of human primary MCs generated from peripheral blood progenitors, sensitized overnight with patients’ sera and activated with allergens. Flow cytometry is used to assess the changes in expression of the activation marker CD63, and the percentage of cell degranulation is defined as the percentage of CD63+-positive MCs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reber LL, Hernandez JD, Galli SJ (2017) The pathophysiology of anaphylaxis. J Allergy Clin Immunol 140(2):335–348
Galli SJ, Tsai M (2012) IgE and mast cells in allergic disease. Nat Med 18(5):693–704
Ladics GS et al (2008) Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract. Regul Toxicol Pharmacol 51(3):288–294
Santos AF et al (2018) A novel human mast cell activation test for peanut allergy. J Allergy Clin Immunol 142(2):689–691.e9
Laidlaw TM et al (2011) Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcepsilonRI. J Allergy Clin Immunol 127(3):815–822. e1–5
Saleh R et al (2014) A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection. Blood 124(1):111–120
Passante E (2014) Mast cell and basophil cell lines: a compendium. Methods Mol Biol 1192:101–113
Thomas K et al (2008) Current and future methods for evaluating the allergenic potential of proteins: international workshop report 23-25 October 2007. Food Chem Toxicol 46(9):3219–3225
Kirshenbaum AS et al (2014) A ten-year retrospective analysis of the distribution, use and phenotypic characteristics of the LAD2 human mast cell line. Int Arch Allergy Immunol 164(4):265–270
Kulka M et al (2008) Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 123(3):398–410
Guhl S et al (2010) Mast cell lines HMC-1 and LAD2 in comparison with mature human skin mast cells - drastically reduced levels of tryptase and chymase in mast cell lines. Exp Dermatol 19(9):845–847
Bahri R et al (2018) Mast cell activation test in the diagnosis of allergic disease and anaphylaxis. J Allergy Clin Immunol 142(2):485–496.e16
Gentek R et al (2018) Hemogenic endothelial fate mapping reveals dual developmental origin of mast cells. Immunity 48(6):1160–1171.e5
Schmetzer O et al (2014) A novel method to generate and culture human mast cells: peripheral CD34+ stem cell-derived mast cells (PSCMCs). J Immunol Methods 413:62–68
Saito H et al (2006) Culture of human mast cells from peripheral blood progenitors. Nat Protoc 1(4):2178–2183
Joulia R et al (2015) Mast cells form antibody-dependent degranulatory synapse for dedicated secretion and defence. Nat Commun 6:6174
Acknowledgments
This research is supported by the following grants: Medical Research Council (MRC) Confidence-in-Concepts award to the University of Manchester (reference MC-PC-15038).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Bahri, R., Bulfone-Paus, S. (2020). Mast Cell Activation Test (MAT). In: Gibbs, B.F., Falcone, F.H. (eds) Basophils and Mast Cells. Methods in Molecular Biology, vol 2163. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0696-4_19
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0696-4_19
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0695-7
Online ISBN: 978-1-0716-0696-4
eBook Packages: Springer Protocols